Titre : Chrysosporium

Chrysosporium : Questions médicales fréquentes

Termes MeSH sélectionnés :

Loneliness
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Chrysosporium : Questions médicales les plus fréquentes", "headline": "Chrysosporium : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Chrysosporium : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-07", "dateModified": "2025-05-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Chrysosporium" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Deuteromycota", "url": "https://questionsmedicales.fr/mesh/D003904", "about": { "@type": "MedicalCondition", "name": "Deuteromycota", "code": { "@type": "MedicalCode", "code": "D003904", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.300.381" } } }, "about": { "@type": "MedicalCondition", "name": "Chrysosporium", "alternateName": "Chrysosporium", "code": { "@type": "MedicalCode", "code": "D002912", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Anwei Chen", "url": "https://questionsmedicales.fr/author/Anwei%20Chen", "affiliation": { "@type": "Organization", "name": "College of Resources and Environment, Hunan Agricultural University, Changsha 410128, PR China. Electronic address: A.Chen@hunau.edu.cn." } }, { "@type": "Person", "name": "Liang Hu", "url": "https://questionsmedicales.fr/author/Liang%20Hu", "affiliation": { "@type": "Organization", "name": "School of Minerals Processing and Bioengineering, Key Laboratory of Biohydrometallurgy of Ministry of Education, Central South University, Changsha 410083, China. Electronic address: huliang2018@csu.edu.cn." } }, { "@type": "Person", "name": "Sheng-Tao Yang", "url": "https://questionsmedicales.fr/author/Sheng-Tao%20Yang", "affiliation": { "@type": "Organization", "name": "College of Chemistry and Environment Protection Engineering, Southwest Minzu University, Chengdu, 610041, PR China. Electronic address: yangst@pku.edu.cn." } }, { "@type": "Person", "name": "Ni He", "url": "https://questionsmedicales.fr/author/Ni%20He", "affiliation": { "@type": "Organization", "name": "School of Minerals Processing and Bioengineering, Key Laboratory of Biohydrometallurgy of Ministry of Education, Central South University, Changsha 410083, China." } }, { "@type": "Person", "name": "Motoyuki Shimizu", "url": "https://questionsmedicales.fr/author/Motoyuki%20Shimizu", "affiliation": { "@type": "Organization", "name": "Department of Applied Biological Chemistry, Faculty of Agriculture, Meijo University, Nagoya, Aichi 468-8502, Japan. Electronic address: moshimi@meijo-u.ac.jp." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Ageing and Loneliness in Times of Pandemic: A Scoping Review.", "datePublished": "2023-03-30", "url": "https://questionsmedicales.fr/article/37047952", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph20075337" } }, { "@type": "ScholarlyArticle", "name": "Effective interventions to reduce loneliness in big cities.", "datePublished": "2022-12-27", "url": "https://questionsmedicales.fr/article/36728699", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/YCO.0000000000000844" } }, { "@type": "ScholarlyArticle", "name": "Impact of Loneliness on Functioning in Lung Cancer Patients.", "datePublished": "2022-11-27", "url": "https://questionsmedicales.fr/article/36497868", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph192315793" } }, { "@type": "ScholarlyArticle", "name": "A network analysis on the relationship between loneliness and schizotypy.", "datePublished": "2022-05-17", "url": "https://questionsmedicales.fr/article/35594977", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jad.2022.05.057" } }, { "@type": "ScholarlyArticle", "name": "Loneliness during the Covid-19 pandemic in Germany: Impact of social factors and polygenic risk scores on interpersonal differences in loneliness and mental health.", "datePublished": "2023-07-31", "url": "https://questionsmedicales.fr/article/37334645", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/15622975.2023.2226201" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Eucaryotes", "item": "https://questionsmedicales.fr/mesh/D056890" }, { "@type": "ListItem", "position": 3, "name": "Champignons", "item": "https://questionsmedicales.fr/mesh/D005658" }, { "@type": "ListItem", "position": 4, "name": "Deuteromycota", "item": "https://questionsmedicales.fr/mesh/D003904" }, { "@type": "ListItem", "position": 5, "name": "Chrysosporium", "item": "https://questionsmedicales.fr/mesh/D002912" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Chrysosporium - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Chrysosporium", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Chrysosporium", "description": "Comment diagnostiquer une infection par Chrysosporium ?\nQuels tests sont utilisés pour identifier Chrysosporium ?\nLes biopsies sont-elles nécessaires pour le diagnostic ?\nQuels symptômes indiquent une infection par Chrysosporium ?\nPeut-on utiliser des tests sérologiques pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=Loneliness&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Chrysosporium", "description": "Quels sont les symptômes courants d'une infection fongique ?\nLes infections cutanées par Chrysosporium sont-elles fréquentes ?\nComment se manifestent les infections pulmonaires ?\nLes infections systémiques sont-elles graves ?\nLes symptômes varient-ils selon l'âge ?", "url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=Loneliness&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Chrysosporium", "description": "Comment prévenir les infections par Chrysosporium ?\nLes personnes immunodéprimées doivent-elles prendre des précautions ?\nLe port de gants est-il recommandé lors de manipulations ?\nLes vaccinations aident-elles à prévenir ces infections ?\nL'hygiène personnelle joue-t-elle un rôle dans la prévention ?", "url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=Loneliness&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Chrysosporium", "description": "Quels traitements sont efficaces contre Chrysosporium ?\nLes traitements varient-ils selon la gravité de l'infection ?\nCombien de temps dure le traitement antifongique ?\nDes effets secondaires sont-ils associés aux antifongiques ?\nLes infections par Chrysosporium nécessitent-elles une hospitalisation ?", "url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=Loneliness&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Chrysosporium", "description": "Quelles complications peuvent survenir avec Chrysosporium ?\nLes infections par Chrysosporium peuvent-elles être mortelles ?\nComment les complications sont-elles gérées ?\nLes complications affectent-elles le pronostic ?\nLes infections récurrentes sont-elles possibles ?", "url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=Loneliness&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Chrysosporium", "description": "Quels sont les principaux facteurs de risque d'infection ?\nLes personnes âgées sont-elles plus à risque ?\nLe diabète augmente-t-il le risque d'infection fongique ?\nLes traitements immunosuppresseurs sont-ils un facteur de risque ?\nLes voyages dans des zones tropicales augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=Loneliness&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection par Chrysosporium ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen microscopique et la culture du champignon." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour identifier Chrysosporium ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de culture et des techniques moléculaires comme la PCR peuvent être utilisés." } }, { "@type": "Question", "name": "Les biopsies sont-elles nécessaires pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des biopsies peuvent être nécessaires pour confirmer l'infection fongique." } }, { "@type": "Question", "name": "Quels symptômes indiquent une infection par Chrysosporium ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure des lésions cutanées, des infections pulmonaires ou systémiques." } }, { "@type": "Question", "name": "Peut-on utiliser des tests sérologiques pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les tests sérologiques ne sont généralement pas fiables pour Chrysosporium." } }, { "@type": "Question", "name": "Quels sont les symptômes courants d'une infection fongique ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fièvre, toux, éruptions cutanées et fatigue." } }, { "@type": "Question", "name": "Les infections cutanées par Chrysosporium sont-elles fréquentes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent provoquer des lésions cutanées et des démangeaisons." } }, { "@type": "Question", "name": "Comment se manifestent les infections pulmonaires ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elles se manifestent par une toux persistante, des douleurs thoraciques et des difficultés respiratoires." } }, { "@type": "Question", "name": "Les infections systémiques sont-elles graves ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être graves et nécessitent une attention médicale immédiate." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de l'âge et de l'état immunitaire." } }, { "@type": "Question", "name": "Comment prévenir les infections par Chrysosporium ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter l'exposition à des environnements humides et à des matériaux contaminés aide à prévenir." } }, { "@type": "Question", "name": "Les personnes immunodéprimées doivent-elles prendre des précautions ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles doivent éviter les environnements à risque et consulter un médecin régulièrement." } }, { "@type": "Question", "name": "Le port de gants est-il recommandé lors de manipulations ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le port de gants lors de la manipulation de terre ou de matériaux potentiellement contaminés est conseillé." } }, { "@type": "Question", "name": "Les vaccinations aident-elles à prévenir ces infections ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Non, il n'existe pas de vaccin spécifique contre les infections par Chrysosporium." } }, { "@type": "Question", "name": "L'hygiène personnelle joue-t-elle un rôle dans la prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une bonne hygiène personnelle peut réduire le risque d'infections fongiques." } }, { "@type": "Question", "name": "Quels traitements sont efficaces contre Chrysosporium ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antifongiques comme l'itraconazole et le voriconazole sont souvent utilisés." } }, { "@type": "Question", "name": "Les traitements varient-ils selon la gravité de l'infection ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections légères peuvent être traitées par voie orale, tandis que les cas graves nécessitent une perfusion." } }, { "@type": "Question", "name": "Combien de temps dure le traitement antifongique ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La durée du traitement peut varier de plusieurs semaines à plusieurs mois selon la gravité." } }, { "@type": "Question", "name": "Des effets secondaires sont-ils associés aux antifongiques ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets secondaires comme des nausées, des éruptions cutanées et des problèmes hépatiques peuvent survenir." } }, { "@type": "Question", "name": "Les infections par Chrysosporium nécessitent-elles une hospitalisation ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Cela dépend de la gravité de l'infection; les cas graves peuvent nécessiter une hospitalisation." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec Chrysosporium ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des infections systémiques graves et des lésions pulmonaires." } }, { "@type": "Question", "name": "Les infections par Chrysosporium peuvent-elles être mortelles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en particulier chez les personnes immunodéprimées, elles peuvent être fatales." } }, { "@type": "Question", "name": "Comment les complications sont-elles gérées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications nécessitent souvent des traitements antifongiques intensifs et un suivi médical." } }, { "@type": "Question", "name": "Les complications affectent-elles le pronostic ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la présence de complications peut aggraver le pronostic et prolonger la durée de traitement." } }, { "@type": "Question", "name": "Les infections récurrentes sont-elles possibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections récurrentes peuvent survenir, surtout chez les patients immunodéprimés." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'infection ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'immunodépression, le diabète et l'exposition à des environnements humides." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un risque accru en raison d'un système immunitaire affaibli." } }, { "@type": "Question", "name": "Le diabète augmente-t-il le risque d'infection fongique ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diabète peut affaiblir le système immunitaire et augmenter le risque d'infections." } }, { "@type": "Question", "name": "Les traitements immunosuppresseurs sont-ils un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements immunosuppresseurs augmentent le risque d'infections fongiques." } }, { "@type": "Question", "name": "Les voyages dans des zones tropicales augmentent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les voyages dans des zones tropicales peuvent exposer à des agents pathogènes fongiques." } } ] } ] }

Sources (1853 au total)

Ageing and Loneliness in Times of Pandemic: A Scoping Review.

Society is immersed in a process of demographic transformation of great relevance: the ageing of the population. During the ageing stage, relevant changes occur, such as age-related losses, lack of fo... Understand, organize and systematically analyse the scientific evidence generated in relation to the impact that the COVID-19 pandemic has had on the processes and feelings of isolation and loneliness... a scoping review was conducted using the methodology of Arksey and O'Malley, which included a review of the studies available in the online databases Proquest, Scopus and WOS. From the search, informa... a total of 32 articles were included, from which three fundamental areas of analysis emerged and three issues emerged: older people and institutionalisation during the pandemic, ageism and hospitalisa... the lack of material resources and infrastructures to be able to face the problem of isolation in institutions was evident. The importance of acquiring, on the part of the elderly, competences, knowle... this study identifies areas already understood, as well as knowledge gaps, that allow for determining opportunities for future research and thus the ability to improve in situations similar to the one...

Effective interventions to reduce loneliness in big cities.

Loneliness is a state of distress or discomfort between the desired and experienced level of connectedness to others. These feelings may be particular salient in urban environments that seemingly offe... Loneliness interventions have predominantly focused on elderly in the community. Adolescents and young adults as a second group at risk have received much less attention. On average across 44 effect s... Scalable and effective interventions for the general population and at-risk groups of loneliness are still scarce. Some promising interventions have been trialled and merit further attention....

Impact of Loneliness on Functioning in Lung Cancer Patients.

Lung cancer is the leading cause of cancer death and carries a greater degree of stigma. Lung cancer stigma contributes to social isolation and increases loneliness, which has an impact on quality of ... The survey study was conducted among 310 lung cancer patients. The patients were asked to complete the Mini-MAC, HADS-M, MNA, EORTC QoL, AIS and VAS questionnaires.... In total, 136 patients were lonely and 174 were married or in a relationship. Lonely patients had significant difficulty accepting their illness and demonstrated higher levels of depression. The facto... Loneliness is a significant factor affecting the functioning of patients with lung cancer. It increases the risk of anxiety and depression, reduces levels of illness acceptance, reduces levels of cons...

A network analysis on the relationship between loneliness and schizotypy.

Schizotypy is a multidimensional personality trait related to the heightened risk for the development of schizophrenia spectrum disorders. While it has been suggested that loneliness may be associated... A demographically diverse sample of young people was obtained from multiple sources. The validated sample consisted of 2089 participants (68.4% female, age range: 18-30). The structural relationship b... 'Suspiciousness', 'odd beliefs or magical thinking', 'no close friends', 'constricted affect' and 'excessive social anxiety' were linked to loneliness directly. Loneliness was found to be more strongl... The use of cross-sectional data indicated only undirected associations between variables.... Loneliness was more strongly linked to some schizotypal traits than others, with the relationships maintaining above and beyond the effects of anxiety and depression. These findings warrant further in...

Loneliness during the Covid-19 pandemic in Germany: Impact of social factors and polygenic risk scores on interpersonal differences in loneliness and mental health.

The outbreak of Covid-19 negatively affected mental health and increased loneliness. The subjective feeling of loneliness is influenced by genetic and social factors and has a negative impact on menta... From March 2020 to June 2021 loneliness was investigated in... Three classes ("average", 40%; "not lonely", 38%; "elevated loneliness", 22%) were identified, that differ significantly regarding loneliness, mental dysfunction, and response to the lockdown phases. ... As the "elevated loneliness" class was at the highest risk of mental dysfunction, our findings underscore the importance of identifying those individuals to implement counteractive measures....

Social isolation, loneliness, and their correlates in older Japanese adults.

Loneliness and social isolation are elevated in older adults and associated with a range of detrimental outcomes. Despite this, there has been little research on these phenomena or on similarities and... Data were analysed from 13 766 adults aged ≥65 years who participated in the 2019 wave of the Japan Gerontological Evaluation Study. Poisson regression analysis was used to examine associations.... Among older Japanese adults, the attributes of higher age, male gender, lower socioeconomic status, being a welfare recipient, and having depressive symptoms were associated with social isolation, whi... Our results indicate that in order to reduce unwanted social isolation and loneliness among older Japanese adults, in the first instance the focus should be on those individuals who are socioeconomica...

Housing and loneliness among individuals with serious mental illnesses.

People with serious mental illnesses (SMI) have higher levels of loneliness than the general population. Furthermore, people with SMI tend to be less satisfied with their housing and tend to move more... This study aims to examine relationships between housing variables (whom they live with, duration of residence, and satisfaction) and loneliness among individuals with SMI.... Data were collected from 188 adults with SMI in greater Philadelphia area. Classification and Regression Trees (CART) were used to examine whether whom they live with, duration of residence, and housi... Housing satisfaction was found to be the most prominent predictor of loneliness. Those who were unsatisfied with their overall housing conditions always had the highest level of loneliness, regardless... Housing is associated with loneliness among people with SMI. Psychiatric service providers should increase support to factors contributing to housing satisfaction and duration of residence, including ...